Lipoceramic Technologies: A Solution To Low And Variable Bioavailability Of Poorly Soluble Anti-inflammatory Drugs
Funder
National Health and Medical Research Council
Funding Amount
$200,600.00
Summary
A novel oral drug delivery platform will be developed that improves the absorption of poorly soluble drugs from the GI tract, leads to improved clinical outcomes and has significant commercial value. This development will be based on the combination of formulation, in vitro analysis and in vivo animal model studies. An advanced prototype formulation will be established for celecoxib (a non-steroidal anti-inflamatory drug) that will be suitable for human phase 1 clinical trials.
Understanding the risk of microplastics in Australian agricultural soils. Biosolids following wastewater treatment are a significant source of microplastics (MPs) that are contaminants of concern. MPs in biosolids pose potential unknown risks to agriculture, food security and ecosystem health through their application to farmlands. Currently, the lack of knowledge on the MPs contamination of agricultural soils is a significant knowledge gap. This project aims to generate new knowledge of MPs' fa ....Understanding the risk of microplastics in Australian agricultural soils. Biosolids following wastewater treatment are a significant source of microplastics (MPs) that are contaminants of concern. MPs in biosolids pose potential unknown risks to agriculture, food security and ecosystem health through their application to farmlands. Currently, the lack of knowledge on the MPs contamination of agricultural soils is a significant knowledge gap. This project aims to generate new knowledge of MPs' fate, behaviour, risk and associated contaminants in biosolids and sludge-amended agricultural soils. The new knowledge generated in this project is expected to help devise better management options to minimise the MP associated risks in agricultural soils, thereby safeguarding the food security and soil health.Read moreRead less
Predictors Of Cardiovascular Disease Mortality In The Melbourne Collaborative Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$350,544.00
Summary
The Melbourne Collaborative Cohort Study was set up in the early 1990s to investigate prospectively the role of diet and other lifestyle factors in causing common chronic diseases including common cancers and cardiovascular disease. Between 1990 and 1994, 41,500 people, aged 40-69 were recruited into the MCCS. About 30% of the cohort are southern European migrants to Australia who were deliberately over-sampled to extend the range of dietary and lifestyle exposures. Migrants from southern Europe ....The Melbourne Collaborative Cohort Study was set up in the early 1990s to investigate prospectively the role of diet and other lifestyle factors in causing common chronic diseases including common cancers and cardiovascular disease. Between 1990 and 1994, 41,500 people, aged 40-69 were recruited into the MCCS. About 30% of the cohort are southern European migrants to Australia who were deliberately over-sampled to extend the range of dietary and lifestyle exposures. Migrants from southern Europe have an adverse risk factor profile in relation to obesity, body fat distribution, physical activity patterns, diabetes, smoking, blood pressure and cholesterol levels, yet their death rates from heart disease are 30-40% lower than the Australian average. A major objective of this study is to investigate the possibility that particular aspects of the diet and cuisine of migrants from southern Europe (olive oil as the major dietary fat, and high intakes of a variety of vegetables and fruit) protect against heart disease and stroke by providing high levels of a wide range of natural antioxidants. It represents the most comprehensive prospective study of diet and cardiovascular disease mortality ever conducted in Australia. A particularly powerful feature is the combination of detailed self-reported dietary intake, the very wide range of exposures to dietary factors implicated in CVD (as risk factors or protective agents), and the objective markers of dietary intake (biochemical markers of dietary intake patterns in blood collected at recruitment, body weight, body fat and body fat distribution). The data should provide a strong rationale for specific dietary recommendations as part of population-based strategies to reduce the incidence of premature mortality from heart disease and stroke in the Australian population.Read moreRead less